Paragraph 2 I1F1
England and Wales
Where the inquiry concerns representations F2or suspension proceedings, the person holding it may send to any F3Health Authority or Primary Care Trust which is not a party but in whose medical, dental, ophthalmic or pharmaceutical list the respondent’s name is included F4(or, in the case of representations made under the 1997 Act, in whose medical list the respondent is seeking to be included) a notice of the date, time and place of the hearing.
Annotations
Textual amendments
- F1
Regulations revoked (E.) by The National Health Service (Pharmaceutical Services) Regulations 2012 (S.I. 2012/1909), reg. 1, Sch. 8 para. 1(1)(a)
- F2
Words in Sch. 9 para. 2 inserted (21.12.1995) by The National Health Service (Service Committees and Tribunal) Amendment Regulations 1995 (S.I. 1995/3091), regs. 1(1), 11(2) (with reg. 15(2))
- F3
Words in Sch. 9 para. 2 substituted (1.10.2002) by The National Health Service Reform and Health Care Professions Act 2002 (Supplementary, Consequential etc. Provisions) Regulations 2002 (S.I. 2002/2469), regs. 1, 13, Sch. 10 (with Sch. 12 Pts. 1, 2)
- F4
Words in Sch. 9 para. 2 inserted (1.4.1998) by The National Health Service (Service Committees and Tribunal) Amendment Regulations 1998 (S.I. 1998/674), regs. 1(1), 14(3)
Commencement
- I1
Sch. 9 para. 2 in force at 1.4.1992, see reg. 1